Moderna
Trade Moderna 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRNA
Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.
MRNA Key Statistics
Stock Snapshot
With a market cap of 9.27B, Moderna(MRNA) trades at $23.66. The stock has a price-to-earnings ratio of -2.94.
On 2025-11-21, Moderna(MRNA) stock traded between a low of $22.27 and a high of $23.94. Shares are currently priced at $23.66, which is +6.3% above the low and -1.1% below the high.
Moderna(MRNA) shares are trading with a volume of 13.9M, against a daily average of 10.77M.
During the past year, Moderna(MRNA) stock moved between $22.27 at its lowest and $48.92 at its peak.
During the past year, Moderna(MRNA) stock moved between $22.27 at its lowest and $48.92 at its peak.
MRNA News
RBC Capital analyst Luca Issi lowered the firm’s price target on Moderna (MRNA) to $25 from $28 and keeps a Sector Perform rating on the shares after its Analys...
Leerink Partners analyst Mani Foroohar maintained a Sell rating on Moderna today and set a price target of $18.00. TipRanks Black Friday Sale Claim 60% off TipR...
Leerink raised the firm’s price target on Moderna (MRNA) to $18 from $15 and keeps an Underperform rating on the shares following the company’s annual Investor...
Analyst ratings
62%
of 26 ratingsMore MRNA News
Citi analyst Geoff Meacham maintained a Hold rating on Moderna yesterday and set a price target of $28.00. TipRanks Black Friday Sale Claim 60% off TipRanks Pre...
Analyst David Dai from UBS maintained a Buy rating on Moderna and keeping the price target at $40.00. TipRanks Black Friday Sale Claim 60% off TipRanks Premium...
Shares of Moderna, Inc. (NASDAQ:MRNA) are falling Thursday. The Massachusetts-based biotech company made two significant announcements regarding its finances an...
TipRanks Black Friday Sale Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to Tip...
Moderna (MRNA) steps into Thursday’s analyst day with more pressure than momentum. The stock is down more than 40% this year and over 85% in three years. Revenu...
Biotech and Pharma Moderna Will Talk to Analysts on Thursday. It Needs to Stop Burning Through Cash. In this article MRNA Moderna is hosting an analyst day on T...
Moderna (MRNA) announced on Wednesday that it has completed its domestic end-to-end mRNA manufacturing network with the onshoring of drug product manufacturing...
